Our Executive Team is comprised of leaders who reflect the values from both Upsher-Smith and our owner, Sawai Group Holdings Co., Ltd.
President & COO
As President & COO, Rich is responsible for driving the growth and strategic direction at Upsher-Smith.
Rich began his career as an engineer in the aerospace industry, working for General Dynamics, Space Systems Division in San Diego. In 1992 he transitioned to Brady Corporation where he headed an engineering group responsible for the design of electromechanical systems and authored 3 patents.
Rich joined Upsher-Smith in 2004 and progressively took on increasing roles of responsibility including Portfolio Management and Business Development, eventually assuming the role as the leader of Corporate Strategy.
Rich holds a B.S. in Engineering from Montana State University and a M.B.A. from the University of St. Thomas.
Chairman of the Board, Upsher-Smith Laboratories, LLC and Group Chief Officer, USA Business, Sawai Group Holdings Co., Ltd.
As Chairman of the Board for Upsher-Smith Laboratories, LLC, Masahiro Sasaki is the most senior Sawai executive serving on-site at Upsher-Smith. He works with Upsher-Smith President & COO Rich Fisher to lead strategy and decision-making for the U.S. pharmaceutical company and is instrumental in working to generate and leverage synergies between the two companies.
Masahiro became Chairman in June 2020, having previously served as Vice Chairman. He also serves as Group Chief Officer, USA Business, Sawai Group Holdings Co., Ltd., having joined the company in 2013. Before that, he served in numerous medical and healthcare business roles for 37 years at Sumitomo Corp., which also currently owns a stake in Upsher-Smith.
Masahiro earned a Bachelor of Science in Pharmaceutical Science from The University of Tokyo.